3D Printed Drugs Market
Penetration of Technological Advancements in Manufacturing Processes to widen prospects for 3D Printed Drugs
3D Printed Drugs Market By Dosage Form, Technology & Region - Forecast 2022 - 2032
3D Printed Drugs Market Snapshot (2022-2032)
[299 Pages Report] The global 3D printed drugs market is expected to garner a market value of US$ 307.54 Million in 2022 and is expected to accumulate a market value of US$ 742.88 Million by registering a CAGR of 9.2% in the forecast period 2022-2032. Growth of the 3D printed drugs market can be attributed to the increasing demand for customized drugs from different age groups. The market for 3D printed drugs registered a CAGR of 6.5% in the historical period 2016-2021.
|
Data Points |
Key Statistics |
|
Estimated Base Year Value (2021) |
US$ 282.14 Million |
|
Expected Market Value (2022) |
US$ 307.54 Million |
|
Anticipated Forecast Value (2032) |
US$ 742.88 Million |
|
Projected Growth Rate (2022-2032) |
9.2% CAGR |
3D printing was pioneered way back in 1986 but has recently begun to enter the public consciousness. Over the past ten years, it has blurred the boundaries between science fiction and fact. It is also known as Additive Manufacturing and is used in the automobile industry, aerospace & defence, retail and in the medical healthcare industry, amongst many others.
A major component of this is the 3D printed drugs market. 3D printing helps make what was once expensive and inaccessible much more cost-effective. Can this be more apt and necessary anywhere else than in the field of medicine? 3D printing is already used to print artificial bones, to create surgical materials with 3D scans to replace a damaged or missing bone and even to create hearing aid devices. Skull implants have been made for people with head injuries and even titanium heels to replace bone cancer afflicted patients.
Let us know your requirement to get
100% FREE customization
2016-2021 3D Printed Drugs Demand Analysis vs. Forecast 2022-2032
The global demand for 3D printed drugs is projected to increase at a CAGR of 9.2% during the forecast period between 2022 and 2032, reaching a total of US$ 307.54 Million in 2032, according to a report from Future Market Insights (FMI). From 2016 to 2021, sales witnessed significant growth, registering a CAGR of 6.5%.
3D printed drugs are prominently being used in the healthcare sector since a long time. The use of 3D printing to produce drugs is not only helping the healthcare sector to grow at a rapid speed but also is helping in saving expenses. The COVID-19 pandemic accelerated the use of 3D printed drugs and affected the market positively.
As technological advancements are shaping the pharmaceutical industry, development of 3D printed drugs has accelerated at a humongous scale. Moreover, with more people being diagnosed with chronic diseases, the demand for 3D printed drugs is expected to increase.
Which are Some Prominent Drivers of 3D Printed Drugs Market?
There are several factors which help the 3D printed drugs sales to grow. One key advantage is their instantaneous solubility. 3D printed drugs are produced using powder bed inkjet printing. The elements of the drug are added in a layer-by-layer approach akin to 3D printing for any other device.
This makes the drugs easier to swallow and can be very helpful for patients suffering from dysphagia. 3D printing could also augment the arrival of individualized drugs or the creation of a combination of drugs. They could be customized for each patient, which would help much more than batch-produced drugs since they would be created specifically taking into account that patient’s medical history.
3D printed drugs could also make children far less resistant to taking the required medication, since they may be able to choose the shape, colour, design and even taste of the tablet! These are anticipated to be the main drivers of the 3D printed drug market.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Challenges Faced by the 3D Printed Drugs Market?
Any new technology adopted will inevitably have some downsides and it can sometimes be a race against time to anticipate and then mitigate them. With regards to the 3D printed drugs market, a 3D blueprint has to be made of the patient, their medical history, the dosage required etc.
With many scandals surrounding hacking and phishing of data stored online & on the cloud entering the mainstream consciousness, patients might be reluctant to disclose their medical information for 3D printed drugs. Another issue could be regarding mislabelling of blueprints, filling the wrong description or even having a higher dosage strength than advertised.
3D printing becoming commonplace could also be used to print illegal drugs, which will do little to help authorities stop the thriving black market trade for them. The main challenge for the 3D printed drugs market, however, would be a lack of regulation.
Most local, domestic and international regulatory bodies have no clear laws regarding 3D printing. There is a question concerning whom the liability will fall on should the drug lead to an adverse reaction – the 3D printing company, medicine Company, or the ingredients supplier.
Global nature of drugs is also another problem. Drug companies involved in the 3D printed drugs market would need to ensure that the right packaging and user instructions are accessible. It can also be a major issue printing drugs in a country which has no clear laws regarding its approval.
Region-Wise Insights
Research and Development Contributing to 3D Printed Drugs Market in Europe?
Development of pharmaceutical sector bolstering growth of 3D printed drugs
The dominant role played by pharmaceutical companies in the U.K. along with them having a strong domestic healthcare infrastructure is contributing to the growth of the 3D drug printed market.
Moreover, the pharmaceutical sector is highly dependent on research and development spending which also explains their reason for the growth of the market. Thus, due to the reasons mentioned above, Europe is expected to procure 29.9% market share as of 2022.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Chronic Diseases Inflcuening Growth of 3D Printed Drugs in North America?
Technological developments spurring growth of 3D printed drugs
Increasing incidences of chronic diseases especially in the geriatric population is accelerating the demand for 3D printed drugs in North America. In addition, the presence of excellent domestic healthcare infrastructure in U.S. and Canada are positively influencing the growth of 3D printed drugs.
Strong investment in research and development along with expanding use of technological developments is further bolstering the demand for 3D printed drugs in the North America region. Thus, owing to the aforementioned reasons, North America is expected to possess 31.1% for 3D printed drugs in 2022.
Clinical Development Frameworks Changing Landscape for 3D Printed Drugs in Asia Pacific?
Emerging economies creating lucrative opportunities for development of 3D printed drugs
Significant developments by China and Japan in the technological integration of 3D printed drug methodologies is driving the growth of the 3D printed drugs market in Asia Pacific. In addition, use of technology is shaping the 3D printed drugs market in the region.
Moreover, the development of healthcare infrastructure, R&D, and clinical development frameworks of emerging economies such as India and Australia have poised the Asia Pacific market to witness lucrative opportunities and growth throughout the forecast period. Thus, Asia Pacific is expected to hold 27% market share in 2022.
Category-Wise Insights
Growing Awareness of Inkjet Printer Technology Spurring growth of 3D Printed Drugs?
Technological superiorities easing the use of inkjet printers
Inkjet printing is a method of depositing three-dimensional shapes in solid dosage forms by spraying various combinations of active pharmaceutical ingredients and excipients (inks) through a nozzle. Inkjet technology generates 3D drugs at a steady rate and has technological superiorities over other techniques. Moreover, it has a high adoption rate among patients.
Furthermore, increased epilepsy incidences along with technological advancements in 3D printing technology, and expanding awareness of this technology in emerging nations are primary market growth drivers. Thus, inkjet printer technology is expected to hold 24% market share for 3D printed drugs in 2022.
Hospitals and Clinics Favouring Production of On-Demand Manufacturing of Medicines?
Easy installation and less wastage accelerating production of 3D printed medicines in hospitals and clinics
Growth of hospitals and clinics is driven by the growing demand for pharmaceuticals and cost-effective use of bio-drugs employing this technology. In addition, widespread use of prescription pills to treat a variety of chronic diseases is increasing the dependency on personalized pharmaceuticals.
Additionally, it can considerably save expenses, waste, and environmental strain. Furthermore, in hospitals and clinics, these printers can be installed to enable the on-demand manufacturing of medications, specifically those with poor stability or that need to be stored in a cold chain. Thus, hospitals and clinics are expected to possess 45% market share for 3D printed drugs market.
Start-Ups for 3D Printed Drugs Market
Key start-up players in the 3D printed drugs market are 3D LifePrints, BellaSeno, Multiply Labs, BioSpaein and AMSystems Center.
- BellaSeno, a key player in the 3D printed drugs market is focusing on providing breasts scaffolds that are 3D printed with biocompatible absorbable polymers. This helps patients to recover from mastectomy.
- AMSystems Center, another key player in the 3D printed drugs market is focusing on using 3D printing technology to manufacture medicines and use the same for other pharma applications such as bio-interfaces and drug-eluting capabilities.
Market Competition
Key players in the 3D printed drugs market are Hewlett Packard Caribe, Merck, Cycle Pharmaceuticals, AstraZeneca, Aprecia, Osmotica Pharmaceuticals, Aprecia Pharmaceuticals LLC Extend Biosciences, Bioduro, Affinity Therapeutics, GlaxoSmithKline Plc and FabRx Ltd
- In September 2021, Cycle Pharmaceuticals has launched SAJAZIR injection. The injection can be used for hereditary angioedema. The company is focusing on producing therapeutic products by using 3D printed drug technology.
- In April 2021, Aprecia Pharmaceuticals collaborated with Nanofarm to advance 3D printed nanomedicines. The company is focusing on providing customer and pharmaceutical industries with new capabilities in patient centric therapies.
Report Scope
|
Report Attribute |
Details |
|
Market Value in 2022 |
US$ 307.54 Million |
|
Market Value in 2032 |
US$ 742.88 Million |
|
Growth Rate |
CAGR of 9.2% from 2022 to 2032 |
|
Base Year for Estimation |
2021 |
|
Historical Data |
2017-2021 |
|
Forecast Period |
2022-2032 |
|
Quantitative Units |
Revenue in USD Million and CAGR from 2022-2032 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments Profiled in the 3D Printed Drugs Market Industry Survey
3D Printed Drugs Market by Dosage Form:
- 3D Printed Tablets
- 3D Printed Capsules
- 3D Printed Multi Drug Implants
- 3D Printed Nanoparticles
- 3D Printed Solutions
- Other 3D Printed Drug Dosage Forms
3D Printed Drugs Market by Technology:
- Inkjet 3D Printed Drugs
- Direct Write 3D Printed Drugs
- Zip Dose 3D Printed Drugs
- Thermal Inkjet 3D Printed Drugs
- 3D Printed Drugs based on Fused Deposition Modeling
- Powder Bed 3D Printed Drugs
- Stereo Lithography (SLA) 3D Printed Drugs
- Semi Solid Extrusion (SSE) 3D Printed Drugs
3D Printed Drugs Market by Region:
- North America 3D Printed Drugs Market
- Latin America 3D Printed Drugs Market
- Europe 3D Printed Drugs Market
- Asia Pacific 3D Printed Drugs Market
- Middle East & Africa 3D Printed Drugs Market
Frequently Asked Questions
FMI projects the global 3D printed drugs market to expand at a 9.2% value CAGR by 2032
The global 3D printed drugs market is estimated at a market value of US$ 307.54 Million
The global 3D printed drugs market is expected to garner a market value of US$ 742.88 Million
North America is expected to possess 31.1% for 3D printed drugs in the assessment period 2022-2032
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global 3D Printed Drugs Market Analysis 2016-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2016-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global 3D Printed Drugs Market Analysis 2016-2021 and Forecast 2022-2032, By Dosage Form
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Dosage Form, 2016-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Dosage Form, 2022-2032
5.3.1. Tablets
5.3.2. Capsules
5.3.3. Multi Drug Implants
5.3.4. Nanoparticles
5.3.5. Solutions
5.3.6. Others
5.4. Y-o-Y Growth Trend Analysis By Dosage Form, 2016-2021
5.5. Absolute $ Opportunity Analysis By Dosage Form, 2022-2032
6. Global 3D Printed Drugs Market Analysis 2016-2021 and Forecast 2022-2032, By Technology
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Technology, 2016-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Technology, 2022-2032
6.3.1. Inkjet Printing
6.3.2. Direct Write
6.3.3. Zip Dose
6.3.4. Thermal Inkjet Printing
6.3.5. Fused Deposition Modelling
6.3.6. Powder Bed Printing
6.3.7. Stereo Lithography (SLA)
6.3.8. Semi Solid Extrusion (SSE)
6.4. Y-o-Y Growth Trend Analysis By Technology, 2016-2021
6.5. Absolute $ Opportunity Analysis By Technology, 2022-2032
7. Global 3D Printed Drugs Market Analysis 2016-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2016-2021
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. MEA
7.4. Market Attractiveness Analysis By Region
8. North America 3D Printed Drugs Market Analysis 2016-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. US
8.2.1.2. Canada
8.2.2. By Dosage Form
8.2.3. By Technology
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Dosage Form
8.3.3. By Technology
8.4. Key Takeaways
9. Latin America 3D Printed Drugs Market Analysis 2016-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Dosage Form
9.2.3. By Technology
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Dosage Form
9.3.3. By Technology
9.4. Key Takeaways
10. Europe 3D Printed Drugs Market Analysis 2016-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Dosage Form
10.2.3. By Technology
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Dosage Form
10.3.3. By Technology
10.4. Key Takeaways
11. Asia Pacific 3D Printed Drugs Market Analysis 2016-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. Rest of Asia Pacific
11.2.2. By Dosage Form
11.2.3. By Technology
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Dosage Form
11.3.3. By Technology
11.4. Key Takeaways
12. MEA 3D Printed Drugs Market Analysis 2016-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of MEA
12.2.2. By Dosage Form
12.2.3. By Technology
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Dosage Form
12.3.3. By Technology
12.4. Key Takeaways
13. Key Countries 3D Printed Drugs Market Analysis
13.1. US
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2021
13.1.2.1. By Dosage Form
13.1.2.2. By Technology
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2021
13.2.2.1. By Dosage Form
13.2.2.2. By Technology
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2021
13.3.2.1. By Dosage Form
13.3.2.2. By Technology
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2021
13.4.2.1. By Dosage Form
13.4.2.2. By Technology
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2021
13.5.2.1. By Dosage Form
13.5.2.2. By Technology
13.6. U.K.
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2021
13.6.2.1. By Dosage Form
13.6.2.2. By Technology
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2021
13.7.2.1. By Dosage Form
13.7.2.2. By Technology
13.8. Spain
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2021
13.8.2.1. By Dosage Form
13.8.2.2. By Technology
13.9. Italy
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2021
13.9.2.1. By Dosage Form
13.9.2.2. By Technology
13.10. China
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2021
13.10.2.1. By Dosage Form
13.10.2.2. By Technology
13.11. Japan
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2021
13.11.2.1. By Dosage Form
13.11.2.2. By Technology
13.12. South Korea
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2021
13.12.2.1. By Dosage Form
13.12.2.2. By Technology
13.13. GCC Countries
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2021
13.13.2.1. By Dosage Form
13.13.2.2. By Technology
13.14. South Africa
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2021
13.14.2.1. By Dosage Form
13.14.2.2. By Technology
13.15. Israel
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2021
13.15.2.1. By Dosage Form
13.15.2.2. By Technology
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Dosage Form
14.3.3. By Technology
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Aprecia
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. FabRx LTD
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. Extend Biosciences
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Bioduro
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. Affinity Therapeutics
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. Tvasta
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. Merck KGaA
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. Terumo Corporation
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.9. Cycle Pharmaceuticals
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.10. AstraZeneca
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
15.1.11. GlaxoSmithKline Plc
15.1.11.1. Overview
15.1.11.2. Product Portfolio
15.1.11.3. Profitability by Market Segments
15.1.11.4. Sales Footprint
15.1.11.5. Strategy Overview
15.1.11.5.1. Marketing Strategy
15.1.12. Osmotica Pharmaceuticals
15.1.12.1. Overview
15.1.12.2. Product Portfolio
15.1.12.3. Profitability by Market Segments
15.1.12.4. Sales Footprint
15.1.12.5. Strategy Overview
15.1.12.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global 3D Printed Drugs Market Value (US$ Mn) Forecast by Region, 2016-2032
Table 2: Global 3D Printed Drugs Market Value (US$ Mn) Forecast by Dosage Form, 2016-2032
Table 3: Global 3D Printed Drugs Market Value (US$ Mn) Forecast by Technology, 2016-2032
Table 4: North America 3D Printed Drugs Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 5: North America 3D Printed Drugs Market Value (US$ Mn) Forecast by Dosage Form, 2016-2032
Table 6: North America 3D Printed Drugs Market Value (US$ Mn) Forecast by Technology, 2016-2032
Table 7: Latin America 3D Printed Drugs Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 8: Latin America 3D Printed Drugs Market Value (US$ Mn) Forecast by Dosage Form, 2016-2032
Table 9: Latin America 3D Printed Drugs Market Value (US$ Mn) Forecast by Technology, 2016-2032
Table 10: Europe 3D Printed Drugs Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 11: Europe 3D Printed Drugs Market Value (US$ Mn) Forecast by Dosage Form, 2016-2032
Table 12: Europe 3D Printed Drugs Market Value (US$ Mn) Forecast by Technology, 2016-2032
Table 13: Asia Pacific 3D Printed Drugs Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 14: Asia Pacific 3D Printed Drugs Market Value (US$ Mn) Forecast by Dosage Form, 2016-2032
Table 15: Asia Pacific 3D Printed Drugs Market Value (US$ Mn) Forecast by Technology, 2016-2032
Table 16: MEA 3D Printed Drugs Market Value (US$ Mn) Forecast by Country, 2016-2032
Table 17: MEA 3D Printed Drugs Market Value (US$ Mn) Forecast by Dosage Form, 2016-2032
Table 18: MEA 3D Printed Drugs Market Value (US$ Mn) Forecast by Technology, 2016-2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global 3D Printed Drugs Market Value (US$ Mn) by Dosage Form, 2022-2032
Figure 2: Global 3D Printed Drugs Market Value (US$ Mn) by Technology, 2022-2032
Figure 3: Global 3D Printed Drugs Market Value (US$ Mn) by Region, 2022-2032
Figure 4: Global 3D Printed Drugs Market Value (US$ Mn) Analysis by Region, 2016-2032
Figure 5: Global 3D Printed Drugs Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 6: Global 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 7: Global 3D Printed Drugs Market Value (US$ Mn) Analysis by Dosage Form, 2016-2032
Figure 8: Global 3D Printed Drugs Market Value Share (%) and BPS Analysis by Dosage Form, 2022-2032
Figure 9: Global 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Dosage Form, 2022-2032
Figure 10: Global 3D Printed Drugs Market Value (US$ Mn) Analysis by Technology, 2016-2032
Figure 11: Global 3D Printed Drugs Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 12: Global 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 13: Global 3D Printed Drugs Market Attractiveness by Dosage Form, 2022-2032
Figure 14: Global 3D Printed Drugs Market Attractiveness by Technology, 2022-2032
Figure 15: Global 3D Printed Drugs Market Attractiveness by Region, 2022-2032
Figure 16: North America 3D Printed Drugs Market Value (US$ Mn) by Dosage Form, 2022-2032
Figure 17: North America 3D Printed Drugs Market Value (US$ Mn) by Technology, 2022-2032
Figure 18: North America 3D Printed Drugs Market Value (US$ Mn) by Country, 2022-2032
Figure 19: North America 3D Printed Drugs Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 20: North America 3D Printed Drugs Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 21: North America 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 22: North America 3D Printed Drugs Market Value (US$ Mn) Analysis by Dosage Form, 2016-2032
Figure 23: North America 3D Printed Drugs Market Value Share (%) and BPS Analysis by Dosage Form, 2022-2032
Figure 24: North America 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Dosage Form, 2022-2032
Figure 25: North America 3D Printed Drugs Market Value (US$ Mn) Analysis by Technology, 2016-2032
Figure 26: North America 3D Printed Drugs Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 27: North America 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 28: North America 3D Printed Drugs Market Attractiveness by Dosage Form, 2022-2032
Figure 29: North America 3D Printed Drugs Market Attractiveness by Technology, 2022-2032
Figure 30: North America 3D Printed Drugs Market Attractiveness by Country, 2022-2032
Figure 31: Latin America 3D Printed Drugs Market Value (US$ Mn) by Dosage Form, 2022-2032
Figure 32: Latin America 3D Printed Drugs Market Value (US$ Mn) by Technology, 2022-2032
Figure 33: Latin America 3D Printed Drugs Market Value (US$ Mn) by Country, 2022-2032
Figure 34: Latin America 3D Printed Drugs Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 35: Latin America 3D Printed Drugs Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 36: Latin America 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 37: Latin America 3D Printed Drugs Market Value (US$ Mn) Analysis by Dosage Form, 2016-2032
Figure 38: Latin America 3D Printed Drugs Market Value Share (%) and BPS Analysis by Dosage Form, 2022-2032
Figure 39: Latin America 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Dosage Form, 2022-2032
Figure 40: Latin America 3D Printed Drugs Market Value (US$ Mn) Analysis by Technology, 2016-2032
Figure 41: Latin America 3D Printed Drugs Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 42: Latin America 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 43: Latin America 3D Printed Drugs Market Attractiveness by Dosage Form, 2022-2032
Figure 44: Latin America 3D Printed Drugs Market Attractiveness by Technology, 2022-2032
Figure 45: Latin America 3D Printed Drugs Market Attractiveness by Country, 2022-2032
Figure 46: Europe 3D Printed Drugs Market Value (US$ Mn) by Dosage Form, 2022-2032
Figure 47: Europe 3D Printed Drugs Market Value (US$ Mn) by Technology, 2022-2032
Figure 48: Europe 3D Printed Drugs Market Value (US$ Mn) by Country, 2022-2032
Figure 49: Europe 3D Printed Drugs Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 50: Europe 3D Printed Drugs Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 51: Europe 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 52: Europe 3D Printed Drugs Market Value (US$ Mn) Analysis by Dosage Form, 2016-2032
Figure 53: Europe 3D Printed Drugs Market Value Share (%) and BPS Analysis by Dosage Form, 2022-2032
Figure 54: Europe 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Dosage Form, 2022-2032
Figure 55: Europe 3D Printed Drugs Market Value (US$ Mn) Analysis by Technology, 2016-2032
Figure 56: Europe 3D Printed Drugs Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 57: Europe 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 58: Europe 3D Printed Drugs Market Attractiveness by Dosage Form, 2022-2032
Figure 59: Europe 3D Printed Drugs Market Attractiveness by Technology, 2022-2032
Figure 60: Europe 3D Printed Drugs Market Attractiveness by Country, 2022-2032
Figure 61: Asia Pacific 3D Printed Drugs Market Value (US$ Mn) by Dosage Form, 2022-2032
Figure 62: Asia Pacific 3D Printed Drugs Market Value (US$ Mn) by Technology, 2022-2032
Figure 63: Asia Pacific 3D Printed Drugs Market Value (US$ Mn) by Country, 2022-2032
Figure 64: Asia Pacific 3D Printed Drugs Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 65: Asia Pacific 3D Printed Drugs Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 66: Asia Pacific 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 67: Asia Pacific 3D Printed Drugs Market Value (US$ Mn) Analysis by Dosage Form, 2016-2032
Figure 68: Asia Pacific 3D Printed Drugs Market Value Share (%) and BPS Analysis by Dosage Form, 2022-2032
Figure 69: Asia Pacific 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Dosage Form, 2022-2032
Figure 70: Asia Pacific 3D Printed Drugs Market Value (US$ Mn) Analysis by Technology, 2016-2032
Figure 71: Asia Pacific 3D Printed Drugs Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 72: Asia Pacific 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 73: Asia Pacific 3D Printed Drugs Market Attractiveness by Dosage Form, 2022-2032
Figure 74: Asia Pacific 3D Printed Drugs Market Attractiveness by Technology, 2022-2032
Figure 75: Asia Pacific 3D Printed Drugs Market Attractiveness by Country, 2022-2032
Figure 76: MEA 3D Printed Drugs Market Value (US$ Mn) by Dosage Form, 2022-2032
Figure 77: MEA 3D Printed Drugs Market Value (US$ Mn) by Technology, 2022-2032
Figure 78: MEA 3D Printed Drugs Market Value (US$ Mn) by Country, 2022-2032
Figure 79: MEA 3D Printed Drugs Market Value (US$ Mn) Analysis by Country, 2016-2032
Figure 80: MEA 3D Printed Drugs Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 81: MEA 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 82: MEA 3D Printed Drugs Market Value (US$ Mn) Analysis by Dosage Form, 2016-2032
Figure 83: MEA 3D Printed Drugs Market Value Share (%) and BPS Analysis by Dosage Form, 2022-2032
Figure 84: MEA 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Dosage Form, 2022-2032
Figure 85: MEA 3D Printed Drugs Market Value (US$ Mn) Analysis by Technology, 2016-2032
Figure 86: MEA 3D Printed Drugs Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 87: MEA 3D Printed Drugs Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 88: MEA 3D Printed Drugs Market Attractiveness by Dosage Form, 2022-2032
Figure 89: MEA 3D Printed Drugs Market Attractiveness by Technology, 2022-2032
Figure 90: MEA 3D Printed Drugs Market Attractiveness by Country, 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
